Bolt Biotherapeutics, Inc.

DB:6LP Stock Report

Market Cap: €21.1m

Bolt Biotherapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 6LP?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,524,3053.98%
VC/PE Firms9,334,14724.4%
Institutions9,455,76724.7%
General Public17,958,78346.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 52.61% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.96%
Tang Capital Management, LLC
3,812,773€2.1m0%0.16%
9.2%
Vivo Capital, LLC
3,521,291€1.9m0%0.17%
7.99%
Pivotal BioVenture Partners LLC
3,058,419€1.7m0%0.73%
7.2%
Sofinnova Investment, Inc.
2,754,437€1.5m0%0.14%
3.19%
Edgar Engleman
1,220,281€673.2k0%no data
2.79%
The Vanguard Group, Inc.
1,067,405€588.9k0%no data
2.74%
Samsara BioCapital LLC
1,049,153€578.8k0%0.08%
1.88%
Stanford Management Company
719,546€397.0k0%0.04%
1.31%
Adage Capital Management, L.P.
500,000€275.8k0%no data
1.23%
Newtyn Management, LLC
468,910€258.7k-65.6%0.03%
0.92%
Geode Capital Management, LLC
352,426€194.4k-4.95%no data
0.77%
Renaissance Technologies LLC
294,039€162.2k6.25%no data
0.7%
BlackRock, Inc.
269,608€148.7k0.95%no data
0.64%
ADAR1 Capital Management, LLC
244,966€135.1k31.7%0.03%
0.45%
Kam Chung Leung
173,698€95.8k0%no data
0.39%
Susquehanna International Group, LLP, Asset Management Arm
147,926€81.6k560%no data
0.3%
FMR LLC
115,386€63.7k33.2%no data
0.16%
Bridgeway Capital Management, LLC
60,200€33.2k-29.3%no data
0.15%
PGIM, Inc.
59,200€32.7k8.82%no data
0.12%
State Street Global Advisors, Inc.
47,437€26.2k0%no data
0.12%
Edith Perez
46,612€25.7k0%no data
0.11%
Northern Trust Global Investments
40,895€22.6k0%no data
0.11%
Mariner, LLC
40,535€22.4k0%no data
0.095%
William Quinn
36,272€20.0k0%no data
0.092%
UBS Asset Management AG
35,297€19.5k-27.7%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 10:13
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bolt Biotherapeutics, Inc. is covered by 6 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael SchmidtGuggenheim Securities, LLC
Edward WhiteH.C. Wainwright & Co.
Soumit RoyJonesTrading Institutional Services, LLC